Braxia Scientific Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Expanded clinical infrastructure to support a growing portfolio of clinical trials of novel interventions and for drug discovery; 14 registered clinical trials...
Source: prnewswire.com